854O INTERLINK-1: Phase III study of cetuximab (CTX) ± monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on/after platinum chemotherapy (CT) and previously treated with an immune checkpoint inhibitor (ICI)Jérôme Fayette, Roger B. Cohen, Lisa Licitra et al.|Annals of Oncology|2023Cited by 32
[Preliminary exploration of the applications of five large language models in the field of oral auxiliary diagnosis, treatment and health consultation].Chunlei Han, Yishuang Zhao, Yi‐Chun Liu et al.|PubMed|2025Cited by 0